21,801 Shares in SPDR S&P Biotech ETF $XBI Acquired by Beck Capital Management LLC

Beck Capital Management LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 21,801 shares of the exchange traded fund’s stock, valued at approximately $2,658,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Dynamic Wealth Strategies LLC grew its stake in SPDR S&P Biotech ETF by 3.8% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after acquiring an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 4.0% during the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after purchasing an additional 81 shares during the last quarter. Compass Ion Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 2.6% in the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after purchasing an additional 97 shares in the last quarter. Moors & Cabot Inc. grew its position in shares of SPDR S&P Biotech ETF by 3.8% in the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares in the last quarter. Finally, Kingsview Wealth Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 1.8% in the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock valued at $582,000 after purchasing an additional 103 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $133.79 on Friday. The business’s 50 day moving average price is $132.63 and its 200 day moving average price is $127.12. The company has a market cap of $8.54 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.